fda
fda · page 2
- Pharmaceutical
Europe’s First Ever ‘Whole Plant’ Cannabis Medicine Could be Available by 2026 in Major Step Forward for Non-Opioid Pain Treatment
German pharmaceutical company Vertanical believes it is on course to deliver the first ‘whole-plant’, cannabis medicine with international approval.
- Uncategorized
Two Federal Cannabis Reform Bills Set to Transform Regulation Across US Introduced
Two separate bipartisan cannabis reform bills that, if passed, would transform US cannabis regulation across the country.
- Uncategorized
FDA Hammered by Lawmakers on Capitol Hill for Allowing Intoxicating Hemp Industry to Flourish
The US Food and Drug Administration (FDA) was dragged through the mud by lawmakers yesterday, who said its ‘bureaucratic red tape, inefficiencies, and weak oversight’ was responsible for the flood of intoxicating hemp substances across the country.
- Uncategorized
US Committee Hearing to Examine FDA’s ‘Failure’ to Regulate Intoxicating Hemp Substances
The US House Committee on Oversight and Government Reform is set to hold a hearing to examine the Food and Drug Administration’s (FDA) apparent ‘failure’ to prevent the flood of intoxicating hemp products across the country.
- Uncategorized
DEA Requests Subpoenas to ‘Compel’ FDA Experts to Give Testimony on Cannabis Rescheduling, Amid Accusations It Is Trying to Overwhelm the Process
The US Drug Enforcement Administration (DEA) has formally requested that the Food and Drug Administration be ‘compelled’ by the court to give evidence at the upcoming cannabis rescheduling hearings.
- Hemp Industry
Increasing Crackdown on Hemp in the US Drives $3.1bn Downgrade in Market Expectations
The lack of progress and clarity on regulations surrounding industrial hemp in the US has seen forecasts for the market over the next five years plummet.
- Uncategorized
Regulators Target Delta-8 THC Edibles in Latest Enforcement Action
The US Food and Drug Administration (FDA), alongside the Federal Trade Comission (FTC), has issued a further five ‘warning’ letters to companies illegally selling copycat food items containing Delta-8 THC.
- Uncategorized
Head Of US FDA Says ‘No Reason’ DEA Should Delay Cannabis Rescheduling
The head of the US Food and Drug Administration (FDA), Robert Califf, told elected officials this week that he believes there is ‘no reason for the DEA to delay’ making its decision on cannabis rescheduling.
- Uncategorized
FDA Unveils Details of Cannabis Rescheduling Research, Including Social Media Monitoring
The US Food and Drug Administration (FDA) has released a swathe of new details into the research it conducted into cannabis, ultimately leading it to recommend its rescheduling.
- CBD Market
Hemp Industry Calls on House Energy & Commerce Leaders to Hold Crucial Hearing on FDA Regulation
In a significant move to address the challenges faced by the U.S. hemp industry, 28 non-profit organizations – representing every element of the hemp food chain and every region of the nation – as well as four leading national dietary supplement organizations – sent this compelling letter to the leaders of the House Energy and Commerce…
- Uncategorized
Measure to be Introduced Preventing Federal Legalisation of Cannabis
U.S. Senators Cynthia Lummis (R-WY) and Steve Daines (R-MT) have announced they will be introducing a new bill that would prevent the federal legalisation of cannabis.
- Uncategorized
FDA Must Do Better To Regulate Hemp Products
A subcommittee was held on Thursday which discussed the Food and Drug Administration’s (FDA) lack of progress on the regulation of hemp products.
